CXCR2 antibodies target tumors and neutrophils, enhancing immunotherapy in ARID1A-deficient pancreatic cancer
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
A groundbreaking breakthrough in cancer treatment has emerged from the laboratories of McMaster University, unveiling a novel therapeutic candidate that ...
In a groundbreaking breakthrough that promises to redefine therapeutic strategies for cancer and aging-related diseases, researchers from the MRC Laboratory ...
In a groundbreaking study published in the British Journal of Cancer, researchers have unveiled a promising new therapeutic strategy for ...
In an era where medical science is forging new pathways in understanding diseases and treatment strategies, recent research has unveiled ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine